Opioid use in patients with rheumatoid arthritis 2005–2014: a population-based comparative study

Jorge A. Zamora-Legoff, Sara J. Achenbach, Cynthia Crowson, Megan L. Krause, John Manley III Davis, Eric Lawrence Matteson

Research output: Contribution to journalArticle

19 Citations (Scopus)

Abstract

Opioid prescriptions have seen an increase across the USA, Canada, Europe, and the UK. In the USA, they have quadrupled from 1999 to 2010. Opioid use among patients with rheumatoid arthritis (RA) over time is not well described. This study examined trends of opioid use in patients with RA. Retrospective prescription data was examined from 2005 to 2014 in a population-based incidence cohort of patients with RA by 1987 ACR criteria and comparable non-RA subjects. Differences in opioid use were examined with Poisson models. A total of 501 patients with RA (71 % female) and 532 non-RA subjects (70 % female) were included in the study. Total and chronic opioid use in 2014 was substantial in both cohorts 40 % RA vs 24 % non-RA and 12 % RA vs. 4 % non-RA, respectively. Opioid use increased by 19 % per year in both cohorts during the study period (95 % confidence interval [CI] 1.15, 1.25). Relative risk (RR) of chronic opiate use for RA patients compared to non-RA subjects was highest in adults aged 50–64 years (RR 2.82; 95 % CI 1.43–6.23). RA disease characteristics, biologic use at index, treated depression/fibromyalgia, education, and smoking status were not significantly associated with chronic opiate use. Over a third of patients with RA use opioids in some form, and in more than a tenth use is chronic. Use has increased in recent years. Patients aged 50–64 with RA use substantially more opioids than their non-RA counterparts.

Original languageEnglish (US)
Pages (from-to)1-8
Number of pages8
JournalClinical Rheumatology
DOIs
StateAccepted/In press - Mar 29 2016

Fingerprint

Opioid Analgesics
Rheumatoid Arthritis
Arthritis
Population
Opiate Alkaloids
Prescriptions
Confidence Intervals
Fibromyalgia
Canada
Cohort Studies
Smoking
Depression
Education
Incidence

Keywords

  • Chronic pain management
  • Opioid trends
  • Rheumatoid arthritis

ASJC Scopus subject areas

  • Rheumatology

Cite this

Opioid use in patients with rheumatoid arthritis 2005–2014 : a population-based comparative study. / Zamora-Legoff, Jorge A.; Achenbach, Sara J.; Crowson, Cynthia; Krause, Megan L.; Davis, John Manley III; Matteson, Eric Lawrence.

In: Clinical Rheumatology, 29.03.2016, p. 1-8.

Research output: Contribution to journalArticle

@article{407094f1358646959abb8516ca7ee3a4,
title = "Opioid use in patients with rheumatoid arthritis 2005–2014: a population-based comparative study",
abstract = "Opioid prescriptions have seen an increase across the USA, Canada, Europe, and the UK. In the USA, they have quadrupled from 1999 to 2010. Opioid use among patients with rheumatoid arthritis (RA) over time is not well described. This study examined trends of opioid use in patients with RA. Retrospective prescription data was examined from 2005 to 2014 in a population-based incidence cohort of patients with RA by 1987 ACR criteria and comparable non-RA subjects. Differences in opioid use were examined with Poisson models. A total of 501 patients with RA (71 {\%} female) and 532 non-RA subjects (70 {\%} female) were included in the study. Total and chronic opioid use in 2014 was substantial in both cohorts 40 {\%} RA vs 24 {\%} non-RA and 12 {\%} RA vs. 4 {\%} non-RA, respectively. Opioid use increased by 19 {\%} per year in both cohorts during the study period (95 {\%} confidence interval [CI] 1.15, 1.25). Relative risk (RR) of chronic opiate use for RA patients compared to non-RA subjects was highest in adults aged 50–64 years (RR 2.82; 95 {\%} CI 1.43–6.23). RA disease characteristics, biologic use at index, treated depression/fibromyalgia, education, and smoking status were not significantly associated with chronic opiate use. Over a third of patients with RA use opioids in some form, and in more than a tenth use is chronic. Use has increased in recent years. Patients aged 50–64 with RA use substantially more opioids than their non-RA counterparts.",
keywords = "Chronic pain management, Opioid trends, Rheumatoid arthritis",
author = "Zamora-Legoff, {Jorge A.} and Achenbach, {Sara J.} and Cynthia Crowson and Krause, {Megan L.} and Davis, {John Manley III} and Matteson, {Eric Lawrence}",
year = "2016",
month = "3",
day = "29",
doi = "10.1007/s10067-016-3239-4",
language = "English (US)",
pages = "1--8",
journal = "Clinical Rheumatology",
issn = "0770-3198",
publisher = "Springer London",

}

TY - JOUR

T1 - Opioid use in patients with rheumatoid arthritis 2005–2014

T2 - a population-based comparative study

AU - Zamora-Legoff, Jorge A.

AU - Achenbach, Sara J.

AU - Crowson, Cynthia

AU - Krause, Megan L.

AU - Davis, John Manley III

AU - Matteson, Eric Lawrence

PY - 2016/3/29

Y1 - 2016/3/29

N2 - Opioid prescriptions have seen an increase across the USA, Canada, Europe, and the UK. In the USA, they have quadrupled from 1999 to 2010. Opioid use among patients with rheumatoid arthritis (RA) over time is not well described. This study examined trends of opioid use in patients with RA. Retrospective prescription data was examined from 2005 to 2014 in a population-based incidence cohort of patients with RA by 1987 ACR criteria and comparable non-RA subjects. Differences in opioid use were examined with Poisson models. A total of 501 patients with RA (71 % female) and 532 non-RA subjects (70 % female) were included in the study. Total and chronic opioid use in 2014 was substantial in both cohorts 40 % RA vs 24 % non-RA and 12 % RA vs. 4 % non-RA, respectively. Opioid use increased by 19 % per year in both cohorts during the study period (95 % confidence interval [CI] 1.15, 1.25). Relative risk (RR) of chronic opiate use for RA patients compared to non-RA subjects was highest in adults aged 50–64 years (RR 2.82; 95 % CI 1.43–6.23). RA disease characteristics, biologic use at index, treated depression/fibromyalgia, education, and smoking status were not significantly associated with chronic opiate use. Over a third of patients with RA use opioids in some form, and in more than a tenth use is chronic. Use has increased in recent years. Patients aged 50–64 with RA use substantially more opioids than their non-RA counterparts.

AB - Opioid prescriptions have seen an increase across the USA, Canada, Europe, and the UK. In the USA, they have quadrupled from 1999 to 2010. Opioid use among patients with rheumatoid arthritis (RA) over time is not well described. This study examined trends of opioid use in patients with RA. Retrospective prescription data was examined from 2005 to 2014 in a population-based incidence cohort of patients with RA by 1987 ACR criteria and comparable non-RA subjects. Differences in opioid use were examined with Poisson models. A total of 501 patients with RA (71 % female) and 532 non-RA subjects (70 % female) were included in the study. Total and chronic opioid use in 2014 was substantial in both cohorts 40 % RA vs 24 % non-RA and 12 % RA vs. 4 % non-RA, respectively. Opioid use increased by 19 % per year in both cohorts during the study period (95 % confidence interval [CI] 1.15, 1.25). Relative risk (RR) of chronic opiate use for RA patients compared to non-RA subjects was highest in adults aged 50–64 years (RR 2.82; 95 % CI 1.43–6.23). RA disease characteristics, biologic use at index, treated depression/fibromyalgia, education, and smoking status were not significantly associated with chronic opiate use. Over a third of patients with RA use opioids in some form, and in more than a tenth use is chronic. Use has increased in recent years. Patients aged 50–64 with RA use substantially more opioids than their non-RA counterparts.

KW - Chronic pain management

KW - Opioid trends

KW - Rheumatoid arthritis

UR - http://www.scopus.com/inward/record.url?scp=84962312043&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84962312043&partnerID=8YFLogxK

U2 - 10.1007/s10067-016-3239-4

DO - 10.1007/s10067-016-3239-4

M3 - Article

C2 - 27022929

AN - SCOPUS:84962312043

SP - 1

EP - 8

JO - Clinical Rheumatology

JF - Clinical Rheumatology

SN - 0770-3198

ER -